# David P. Walling, Ph.D. – FDA Inspection, Jan 13, 2023

Source: https://www.keypedia.com/records/fda_inspections/david-p-walling-phd/57c57951-6596-4170-b00f-3c4d9f4e7df5
Source feed: FDA_Inspections

> FDA inspection 1195349 of David P. Walling, Ph.D., January 13, 2023. Classification: Voluntary Action Indicated (VAI). 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1195349
- Company Name: David P. Walling, Ph.D.
- Inspection Date: 2023-01-13
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1143823 - 2021-05-14](https://www.keypedia.com/records/fda_inspections/david-p-walling-phd/54182797-6a79-4873-bd3e-4a0388d50a92)
- FDA Inspection 1063079 - 2018-03-19
- FDA Inspection 917428 - 2015-03-11
- FDA Inspection 911140 - 2015-01-23
- FDA Inspection 879347 - 2014-05-09

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/julian-c-hanson/489e27d9-0de6-4bf0-8aec-e5d500841f52)
- [Issuing Officer](https://www.keypedia.com/people/samson-o-oluseye/bfe102f5-25cb-4ed9-9e69-2ec5ec0a047f)

Company: https://www.keypedia.com/companies/david-p-walling-phd/9e1c45b0-e599-4f02-b965-72551a0d70b6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c